Average Co-Inventor Count = 5.57
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (14 from 2,405 patents)
2. Merck + Co., Inc. (7 from 4,770 patents)
3. Smithkline Beecham Corporation (3 from 2,198 patents)
4. Merck Canada Inc. (1 from 40 patents)
5. Merch Sharp & Dohme Ltd (1 from 4 patents)
25 patents:
1. 11198687 - Heteroaryl allosteric modulators of nicotinic acetylcholine receptors
2. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
3. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
4. 9636337 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
5. 9399651 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
6. 9309199 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
7. 9278960 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
8. 9102673 - Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors
9. 9024032 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
10. 8541595 - Imidazoisoindole neuropeptide S receptor antagonists
11. 8389720 - Quinolone neuropeptide S receptor antagonists
12. 8148535 - Potassium channel inhibitors
13. 7910561 - Inhibitors of Akt activity
14. 7879839 - Potassium channel inhibitors
15. 7750151 - Inhibitors of Akt activity